<code id='568B5F82FD'></code><style id='568B5F82FD'></style>
    • <acronym id='568B5F82FD'></acronym>
      <center id='568B5F82FD'><center id='568B5F82FD'><tfoot id='568B5F82FD'></tfoot></center><abbr id='568B5F82FD'><dir id='568B5F82FD'><tfoot id='568B5F82FD'></tfoot><noframes id='568B5F82FD'>

    • <optgroup id='568B5F82FD'><strike id='568B5F82FD'><sup id='568B5F82FD'></sup></strike><code id='568B5F82FD'></code></optgroup>
        1. <b id='568B5F82FD'><label id='568B5F82FD'><select id='568B5F82FD'><dt id='568B5F82FD'><span id='568B5F82FD'></span></dt></select></label></b><u id='568B5F82FD'></u>
          <i id='568B5F82FD'><strike id='568B5F82FD'><tt id='568B5F82FD'><pre id='568B5F82FD'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:413
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In